Arteris, Inc. Financials
Arteris, Inc. (AIP) reported $70.6M in revenue for fiscal year 2025, up 22.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
High-gross-margin revenue is finally starting to fund itself, but R&D-heavy economics still keep Arteris unprofitable.
The biggest shift is cash conversion: despite a net loss of-$34.7M , operating cash flow turned positive at$6.7M as receivables fell even while revenue expanded, suggesting billing and collections stopped absorbing cash. That matters because earlier growth consumed cash as quickly as it was booked, while the latest year shows the model can self-fund part of its expansion before accounting profit arrives.
Gross margin stayed near
Cash rose to
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Arteris, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Arteris, Inc. scores 3.12, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($1.2B) relative to total liabilities ($129.7M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Arteris, Inc. passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
Arteris, Inc. reported a net loss of $34.7M while generating $6.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Arteris, Inc. reported an operating loss of $33.1M against $193K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Arteris, Inc. generated $70.6M in revenue in fiscal year 2025. This represents an increase of 22.3% from the prior year.
Arteris, Inc.'s EBITDA was -$29.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 5.4% from the prior year.
Arteris, Inc. reported -$34.7M in net income in fiscal year 2025. This represents a decrease of 3.3% from the prior year.
Arteris, Inc. earned -$0.82 per diluted share (EPS) in fiscal year 2025. This represents an increase of 4.7% from the prior year.
Cash & Balance Sheet
Arteris, Inc. generated $5.3M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 612.0% from the prior year.
Arteris, Inc. held $33.9M in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Margins & Returns
Arteris, Inc.'s gross margin was 90.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.6 percentage points from the prior year.
Arteris, Inc.'s operating margin was -46.9% in fiscal year 2025, reflecting core business profitability. This is up 7.8 percentage points from the prior year.
Arteris, Inc.'s net profit margin was -49.2% in fiscal year 2025, showing the share of revenue converted to profit. This is up 9.0 percentage points from the prior year.
Not reported for fiscal year 2025.
Capital Allocation
Arteris, Inc. invested $49.9M in research and development in fiscal year 2025. This represents an increase of 10.9% from the prior year.
Arteris, Inc. invested $1.4M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 328.4% from the prior year.
Not reported for fiscal year 2025.
AIP Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 |
|---|---|---|---|---|---|---|---|
| Revenue | $84.6M | $70.6M+22.3% | $57.7M+7.6% | $53.7M+6.5% | $50.4M+33.0% | $37.9M+19.0% | $31.8M |
| Cost of Revenue | $10.5M | $6.9M+15.6% | $6.0M+17.4% | $5.1M+18.6% | $4.3M+14.7% | $3.7M+150.2% | $1.5M |
| Gross Profit | $74.1M | $63.7M+23.0% | $51.8M+6.5% | $48.6M+5.4% | $46.1M+35.1% | $34.1M+12.6% | $30.3M |
| R&D Expenses | $57.1M | $49.9M+10.9% | $45.0M-0.3% | $45.1M+9.6% | $41.2M+33.6% | $30.8M+81.0% | $17.0M |
| SG&A Expenses | $22.8M | $20.1M+14.7% | $17.6M-2.2% | $17.9M+9.6% | $16.4M+22.5% | $13.4M+82.3% | $7.3M |
| Operating Income | -$40.4M | -$33.1M-4.9% | -$31.6M+10.1% | -$35.1M-21.8% | -$28.9M-32.6% | -$21.8M-476.3% | -$3.8M |
| Interest Expense | $61K | $193K-3.5% | $200K-5.2% | $211K+137.1% | $89K-15.2% | $105K+5.0% | $100K |
| Income Tax | -$2.6M | $1.5M-41.0% | $2.5M+49.1% | $1.7M+502.2% | -$417K-140.1% | $1.0M+1.4% | $1.0M |
| Net Income | -$39.5M | -$34.7M-3.3% | -$33.6M+8.8% | -$36.9M-34.6% | -$27.4M-17.1% | -$23.4M-617.3% | -$3.3M |
| EPS (Diluted) | — | -$0.82+4.7% | -$0.86+16.5% | -$1.03-22.6% | -$0.84+20.8% | -$1.06-457.9% | -$0.19 |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
AIP Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 |
|---|---|---|---|---|---|---|
| Total Assets | $115.0M+8.4% | $106.1M+3.2% | $102.8M-11.0% | $115.5M-4.1% | $120.4M+181.8% | $42.7M |
| Current Assets | $82.4M+19.3% | $69.1M+18.2% | $58.4M-28.0% | $81.1M-23.9% | $106.6M+268.4% | $29.0M |
| Cash & Equivalents | $33.9M+147.7% | $13.7M-0.1% | $13.7M-63.4% | $37.4M-56.4% | $85.8M+630.8% | $11.7M |
| Accounts Receivable | $19.2M-6.9% | $20.6M+71.7% | $12.0M+68.0% | $7.1M-48.5% | $13.9M-3.3% | $14.3M |
| Goodwill | $4.2M0.0% | $4.2M0.0% | $4.2M-0.9% | $4.2M+57.6% | $2.7M0.0% | $2.7M |
| Total Liabilities | $129.7M+20.8% | $107.3M+22.4% | $87.7M+12.5% | $78.0M+15.5% | $67.5M+37.7% | $49.0M |
| Current Liabilities | $73.2M+23.5% | $59.3M+27.8% | $46.4M+6.3% | $43.7M+2.8% | $42.5M+50.5% | $28.2M |
| Total Equity | -$14.6M-1131.6% | -$1.2M-107.9% | $15.1M-59.8% | $37.5M-29.1% | $52.9M+540.6% | -$12.0M |
| Retained Earnings | -$171.6M-25.4% | -$136.9M-32.6% | -$103.2M-55.5% | -$66.4M-70.2% | -$39.0M-149.8% | -$15.6M |
Not reported in any period shown, so not listed: Inventory, Long-Term Debt.
AIP Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $8.5M | $6.7M+1035.1% | -$720K+95.4% | -$15.7M-132.4% | -$6.8M-731.3% | -$814K-137.6% | $2.2M |
| Capital Expenditures | $1.7M | $1.4M+328.4% | $324K-78.4% | $1.5M+43.0% | $1.1M+30.1% | $808K+23.5% | $654K |
| Free Cash Flow | $6.8M | $5.3M+612.0% | -$1.0M+93.9% | -$17.2M-120.4% | -$7.8M-382.0% | -$1.6M-207.5% | $1.5M |
| Investing Cash Flow | -$5.0M | $12.0M+1140.0% | $970K+120.7% | -$4.7M+87.5% | -$37.5M-2658.0% | -$1.4M+73.6% | -$5.1M |
| Financing Cash Flow | $73.6M | $1.4M+640.8% | -$262K+91.0% | -$2.9M+29.7% | -$4.2M-105.4% | $76.3M+9552.4% | $790K |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
AIP Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 |
|---|---|---|---|---|---|---|
| Gross Margin | 90.2%+0.6pp | 89.7%-0.9pp | 90.5%-1.0pp | 91.5%+1.4pp | 90.1%-5.2pp | 95.3% |
| Operating Margin | -46.9%+7.8pp | -54.7%+10.7pp | -65.5%-8.2pp | -57.3%+0.2pp | -57.5%-45.6pp | -11.9% |
| Net Margin | -49.2%+9.0pp | -58.3%+10.4pp | -68.7%-14.3pp | -54.4%+7.4pp | -61.8%-51.5pp | -10.3% |
| Return on Equity | N/A | N/A | -244.1%-171.2pp | -73.0%-28.8pp | -44.2% | N/A |
| Return on Assets | -30.2%+1.5pp | -31.7%+4.2pp | -35.9%-12.1pp | -23.7%-4.3pp | -19.4%-11.8pp | -7.6% |
| Current Ratio | 1.130.0x | 1.17-0.1x | 1.26-0.6x | 1.86-0.7x | 2.51+1.5x | 1.03 |
| Debt-to-Equity | N/A | N/A | 5.81+3.7x | 2.08+0.8x | 1.28 | N/A |
| FCF Margin | 7.6%+9.4pp | -1.8%+30.3pp | -32.1%-16.6pp | -15.5%-11.2pp | -4.3%-9.0pp | 4.7% |
Note: Shareholder equity is negative (-$14.6M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Similar Companies
Where Arteris, Inc. Ranks
Frequently Asked Questions
What is Arteris, Inc.'s annual revenue?
Arteris, Inc. (AIP) reported $70.6M in total revenue for fiscal year 2025. This represents a 22.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Arteris, Inc.'s revenue growing?
Arteris, Inc. (AIP) revenue grew by 22.3% year-over-year, from $57.7M to $70.6M in fiscal year 2025.
Is Arteris, Inc. profitable?
No, Arteris, Inc. (AIP) reported a net income of -$34.7M in fiscal year 2025, with a net profit margin of -49.2%.
What is Arteris, Inc.'s EBITDA?
Arteris, Inc. (AIP) had EBITDA of -$29.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Arteris, Inc.'s gross margin?
Arteris, Inc. (AIP) had a gross margin of 90.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Arteris, Inc.'s operating margin?
Arteris, Inc. (AIP) had an operating margin of -46.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Arteris, Inc.'s net profit margin?
Arteris, Inc. (AIP) had a net profit margin of -49.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Arteris, Inc.'s free cash flow?
Arteris, Inc. (AIP) generated $5.3M in free cash flow during fiscal year 2025. This represents a 612.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Arteris, Inc.'s operating cash flow?
Arteris, Inc. (AIP) generated $6.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Arteris, Inc.'s total assets?
Arteris, Inc. (AIP) had $115.0M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Arteris, Inc.'s capital expenditures?
Arteris, Inc. (AIP) invested $1.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Arteris, Inc. spend on research and development?
Arteris, Inc. (AIP) invested $49.9M in research and development during fiscal year 2025.
What is Arteris, Inc.'s current ratio?
Arteris, Inc. (AIP) had a current ratio of 1.13 as of fiscal year 2025, which is considered adequate.
What is Arteris, Inc.'s return on assets (ROA)?
Arteris, Inc. (AIP) had a return on assets of -30.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Why is Arteris, Inc.'s debt-to-equity ratio negative or not reported?
Arteris, Inc. (AIP) has negative shareholder equity of -$14.6M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Arteris, Inc.'s Altman Z-Score?
Arteris, Inc. (AIP) has an Altman Z-Score of 3.12, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Arteris, Inc.'s Piotroski F-Score?
Arteris, Inc. (AIP) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Arteris, Inc.'s earnings high quality?
Arteris, Inc. (AIP) reported a net loss of $34.7M while generating $6.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Arteris, Inc. cover its interest payments?
Arteris, Inc. (AIP) reported an operating loss of $33.1M against $193K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Arteris, Inc.?
Arteris, Inc. (AIP) scores 69 out of 100 on our Financial Health Score, indicating strong standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.